Cellosaurus BFTC-905-DOXO-II (CVCL_4V69)

Cell line name BFTC-905-DOXO-II
Accession CVCL_4V69
Resource Identification Initiative To cite this cell line use: BFTC-905-DOXO-II (RRID:CVCL_4V69)
Comments Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Disease Bladder carcinoma (NCIt: C4912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1083 (BFTC-905)
Sex of cell Female
Category Cancer cell line
Publications

PubMed=25566959; DOI=10.1007/s13277-014-2959-9
Greife A., Tukova J., Steinhoff C., Scott S.D., Schulz W.A., Hatina J.
Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.
Tumor Biol. 36:3293-3300(2015)